Newsletter - August 16, 2018
Mobile technologies in Clinical Trials: Detailed Roadmap from CTTI and FDA
A report released last month by the Clinical Trial Transformation Initiative (CTTI), a joint venture of FDA and the Duke University, contends that all clinical trials should use mobile technologies to increase patient participation and retention, while reducing cost, increasing efficiency, and capturing real-time and real-world clinical data....Read More
FDA Approval of a Contraceptive Mobile App Shows Why It is Not Worth it
This week FDA approved the first mobile contraceptive app created by a Swedish startup. The app basically uses a calendar connected to temperature reading submitted by the users to calculate their menstrual cycle and predict more fertile days than others... Read More
Mobile technologies in Clinical Trials: Detailed Roadmap from CTTI and FDA
A report released last month by the Clinical Trial Transformation Initiative (CTTI), a joint venture of FDA and the Duke University, contends that all clinical trials should use mobile technologies to increase patient participation and retention, while reducing cost, increasing efficiency, and capturing real-time and real-world clinical data....Read More
FDA Approval of a Contraceptive Mobile App Shows Why It is Not Worth it
This week FDA approved the first mobile contraceptive app created by a Swedish startup. The app basically uses a calendar connected to temperature reading submitted by the users to calculate their menstrual cycle and predict more fertile days than others... Read More
